Granerus M, Engström W
Department of Pathology, Swedish University of Agricultural Sciences, Uppsala, S-750 07, Sweden.
Cell Biol Int. 2001;25(8):825-8. doi: 10.1006/cbir.2001.0756.
Human teratocarcinoma cells (Tera-2) deprived of serum undergo programmed cell death which can be counteracted by simultaneous addition of IGF-I or IGF-II. This protective effect of IGFs was specific in the sense that both addition of IGF-binding protein-2, and blocking of the IGF-type I receptor by a specific antibody, both resulted in an increased apoptotic rate.
缺乏血清的人畸胎瘤细胞(Tera-2)会经历程序性细胞死亡,而同时添加胰岛素样生长因子-I(IGF-I)或胰岛素样生长因子-II(IGF-II)可抵消这种死亡。IGFs的这种保护作用具有特异性,因为添加胰岛素样生长因子结合蛋白-2以及用特异性抗体阻断IGF-I型受体均会导致凋亡率增加。